SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM

SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM was reported 1422 times

SUMATRIPTAN SUCCINATE AND NAPROXEN SODIUM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CARTILAGE DEVELOPMENT DISORDER 1 0.0588
1 BEREAVEMENT 1 0.0217
2 FAECAL CALPROTECTIN 1 0.0156
3 EAR, NOSE AND THROAT INFECTION 1 0.0122
4 SELECTIVE IGG SUBCLASS DEFICIENCY 1 0.0106
5 PAIN THRESHOLD DECREASED 1 0.0082
6 LIPASE DECREASED 1 0.0081
7 BRONCHOMALACIA 1 0.0076
8 HAPTOGLOBIN INCREASED 1 0.0073
9 CHORDEE 1 0.0071
10 ENTEROBIASIS 1 0.0067
11 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 1 0.0057
12 BLOOD COPPER INCREASED 1 0.0056
13 MONOCYTE PERCENTAGE DECREASED 1 0.0054
14 HYDROMETRA 1 0.0054
15 MOUTH CYST 1 0.0053
16 JAW CLICKING 1 0.0047
17 MEDICATION OVERUSE HEADACHE 4 0.0047
18 MITOCHONDRIAL MYOPATHY 1 0.0046
19 BLOOD CREATINE PHOSPHOKINASE ABNORMAL 2 0.0044
20 PENILE CURVATURE 1 0.0043
21 SPINAL INSTABILITY 1 0.0039
22 MONONUCLEOSIS SYNDROME 1 0.0039
23 POST CHOLECYSTECTOMY SYNDROME 1 0.0035
24 CHONDROMALACIA 1 0.0035
25 BED REST 1 0.0032
26 SENSATION OF HEAVINESS 12 0.0031
27 DREAMY STATE 1 0.0031
28 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
29 EMERGENCY CARE EXAMINATION 2 0.0029
30 BILIARY DYSKINESIA 5 0.0029
31 PSEUDOPORPHYRIA 1 0.0029
32 APPLICATION SITE PAPULES 3 0.0028
33 INTRACRANIAL VENOUS SINUS THROMBOSIS 3 0.0028
34 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
35 SALIVARY GLAND CALCULUS 1 0.0027
36 ANASTOMOTIC STENOSIS 1 0.0027
37 PITYRIASIS ROSEA 1 0.0027
38 CARDIAC ASSISTANCE DEVICE USER 1 0.0027
39 ALBUMIN URINE PRESENT 1 0.0026
40 EYE INFECTION FUNGAL 1 0.0026
41 GINGIVAL INFECTION 2 0.0025
42 PARVOVIRUS INFECTION 1 0.0025
43 GRANULOCYTE COUNT INCREASED 1 0.0025
44 PHOTODERMATOSIS 1 0.0024
45 OROPHARYNGEAL SPASM 1 0.0024
46 APPLICATION SITE WARMTH 3 0.0024
47 CITROBACTER INFECTION 1 0.0023
48 MUSCULAR DYSTROPHY 1 0.0023
49 GALLBLADDER CHOLESTEROLOSIS 1 0.0022
50 VASOSPASM 2 0.0022
51 ANGIOSARCOMA 1 0.0022
52 APPLICATION SITE INFLAMMATION 3 0.0022
53 AURA 4 0.0021
54 OPIATES POSITIVE 1 0.0021
55 HYPOAESTHESIA FACIAL 3 0.0020
56 SEPSIS SYNDROME 1 0.0020
57 PO2 INCREASED 1 0.0020
58 BLOOD MAGNESIUM ABNORMAL 1 0.0018
59 PRESBYOPIA 1 0.0018
60 EYE BURNS 1 0.0017
61 APPLICATION SITE DISCOMFORT 3 0.0017
62 INCORRECT DRUG DOSAGE FORM ADMINISTERED 1 0.0016
63 APPLICATION SITE SCAR 2 0.0016
64 RUPTURED CEREBRAL ANEURYSM 1 0.0015
65 APPLICATION SITE PARAESTHESIA 2 0.0015
66 INJECTION SITE EXFOLIATION 1 0.0015
67 ANION GAP INCREASED 2 0.0015
68 BRONCHITIS VIRAL 1 0.0015
69 HAEMATOSPERMIA 1 0.0014
70 OPHTHALMIC MIGRAINE 1 0.0014
71 THERAPEUTIC RESPONSE DELAYED 4 0.0014
72 APPLICATION SITE ULCER 1 0.0014
73 PREGNANCY OF PARTNER 1 0.0014
74 PCO2 INCREASED 1 0.0014
75 JARISCH-HERXHEIMER REACTION 1 0.0014
76 CARDIAC ENZYMES INCREASED 1 0.0014
77 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
78 SMALL FIBRE NEUROPATHY 1 0.0014
79 AXILLARY PAIN 2 0.0013
80 CHOLECYSTITIS CHRONIC 9 0.0013
81 BLOOD FIBRINOGEN INCREASED 1 0.0013
82 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
83 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
84 CAMPYLOBACTER INFECTION 1 0.0012
85 DENTAL DISCOMFORT 1 0.0012
86 PERIORBITAL PAIN 1 0.0012
87 HANGOVER 4 0.0011
88 SENSATION OF PRESSURE 1 0.0011
89 SALIVA ALTERED 1 0.0011
90 MUSCLE TIGHTNESS 18 0.0011
91 BLOOD MAGNESIUM INCREASED 1 0.0011
92 NUCHAL RIGIDITY 1 0.0011
93 BONE CONTUSION 1 0.0011
94 PLEURITIC PAIN 3 0.0011
95 DRUG SCREEN FALSE POSITIVE 3 0.0011
96 MENINGIOMA BENIGN 1 0.0011
97 FEELING DRUNK 8 0.0011
98 ARNOLD-CHIARI MALFORMATION 1 0.0010
99 PROSTATE INFECTION 1 0.0010
100 INJECTION SITE SCAB 1 0.0010
101 PCO2 DECREASED 1 0.0010
102 THROAT TIGHTNESS 28 0.0010
103 CORRECTIVE LENS USER 1 0.0010
104 APPLICATION SITE BURN 5 0.0010
105 HAEMANGIOMA OF LIVER 1 0.0010
106 APPLICATION SITE DISCOLOURATION 4 0.0010
107 BENIGN BREAST NEOPLASM 1 0.0010
108 EYELID PAIN 2 0.0010
109 MIGRAINE 93 0.0010
110 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 2 0.0010
111 PRE-EXISTING CONDITION IMPROVED 6 0.0010
112 BLAST CELL COUNT INCREASED 1 0.0010
113 APPLICATION SITE SCAB 2 0.0009
114 OEDEMA MOUTH 3 0.0009
115 INFECTIOUS MONONUCLEOSIS 2 0.0009
116 DRUG EFFECT VARIABLE 1 0.0009
117 MOANING 1 0.0009
118 PO2 DECREASED 1 0.0009
119 CARBON DIOXIDE DECREASED 1 0.0009
120 DISTRACTIBILITY 1 0.0009
121 PALMAR ERYTHEMA 1 0.0009
122 PERFORMANCE STATUS DECREASED 4 0.0009
123 ORAL SURGERY 2 0.0009
124 PROCALCITONIN INCREASED 1 0.0009
125 APPENDICECTOMY 3 0.0008
126 PULSE ABNORMAL 2 0.0008
127 EXPIRED DRUG ADMINISTERED 4 0.0008
128 BLOOD UREA DECREASED 1 0.0008
129 APPLICATION SITE EROSION 1 0.0008
130 DACRYOSTENOSIS ACQUIRED 1 0.0008
131 OBSTRUCTION 3 0.0008
132 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
133 ARTERIOSPASM CORONARY 3 0.0007
134 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0007
135 GALLBLADDER OPERATION 3 0.0007
136 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
137 BODY MASS INDEX INCREASED 1 0.0007
138 NONSPECIFIC REACTION 4 0.0007
139 JOINT INSTABILITY 1 0.0007
140 NECK MASS 2 0.0007
141 SMEAR CERVIX ABNORMAL 1 0.0007
142 NOROVIRUS INFECTION 1 0.0007
143 JUDGEMENT IMPAIRED 1 0.0007
144 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
145 NECK INJURY 2 0.0007
146 SLEEP PARALYSIS 1 0.0007
147 LIGAMENT RUPTURE 3 0.0007
148 GENITAL PAIN 1 0.0007
149 REBOUND ACID HYPERSECRETION 2 0.0007
150 INJECTION SITE PAPULE 3 0.0007
151 ORAL MUCOSAL ERUPTION 1 0.0007
152 MEAN CELL VOLUME DECREASED 1 0.0006
153 POLYCYSTIC OVARIES 1 0.0006
154 IDIOPATHIC THROMBOCYTOPENIC PURPURA 1 0.0006
155 DRUG SCREEN POSITIVE 5 0.0006
156 NASAL DISCOMFORT 5 0.0006
157 JC VIRUS INFECTION 1 0.0006
158 DISINHIBITION 1 0.0006
159 GALLBLADDER DISORDER 11 0.0006
160 POSTURE ABNORMAL 2 0.0006
161 MENSTRUAL DISORDER 5 0.0006
162 APPLICATION SITE SWELLING 3 0.0006
163 MITRAL VALVE PROLAPSE 1 0.0006
164 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 1 0.0006
165 ULCER HAEMORRHAGE 4 0.0006
166 SLEEP TALKING 1 0.0006
167 LOWER RESPIRATORY TRACT CONGESTION 1 0.0006
168 BLOOD PH DECREASED 1 0.0006
169 TRISMUS 3 0.0006
170 FOOT FRACTURE 11 0.0006
171 HYSTERECTOMY 5 0.0006
172 MENINGITIS CRYPTOCOCCAL 1 0.0006
173 BURNS SECOND DEGREE 1 0.0006
174 PANCREATIC FAILURE 1 0.0006
175 SKIN HYPOPIGMENTATION 1 0.0006
176 FACIAL PARESIS 2 0.0006
177 FEAR OF DISEASE 1 0.0006
178 JUGULAR VEIN THROMBOSIS 1 0.0006
179 CEREBRAL VENOUS THROMBOSIS 1 0.0006
180 MEAN CELL HAEMOGLOBIN DECREASED 1 0.0005
181 BODY TEMPERATURE ABNORMAL 1 0.0005
182 OESOPHAGEAL SPASM 1 0.0005
183 METAMORPHOPSIA 1 0.0005
184 DENTAL CARE 1 0.0005
185 HYPERACUSIS 2 0.0005
186 NEPHROPATHY 5 0.0005
187 PRODUCT LEAKAGE 3 0.0005
188 PROTEIN TOTAL DECREASED 2 0.0005
189 SNORING 2 0.0005
190 PARANASAL SINUS DISCOMFORT 2 0.0005
191 BLOOD BICARBONATE DECREASED 1 0.0005
192 LIP DISORDER 1 0.0005
193 GUN SHOT WOUND 1 0.0005
194 PANCREATIC CYST 1 0.0005
195 GALLBLADDER INJURY 1 0.0005
196 NASAL SEPTUM DEVIATION 1 0.0005
197 JOINT NOISE 1 0.0005
198 FOREIGN BODY 2 0.0005
199 TRIGEMINAL NEURALGIA 2 0.0005
200 PAIN IN JAW 14 0.0005
201 DRUG ADMINISTRATION ERROR 15 0.0005
202 HYPERAESTHESIA 4 0.0005
203 HYPOSPADIAS 1 0.0005
204 SEROTONIN SYNDROME 9 0.0005
205 HYPERPHOSPHATAEMIA 1 0.0005
206 TENSION HEADACHE 2 0.0005
207 DEREALISATION 1 0.0005
208 FACIAL PALSY 1 0.0005
209 CERVICAL DYSPLASIA 1 0.0005
210 TONGUE DISCOLOURATION 2 0.0005
211 PHARYNGEAL OEDEMA 7 0.0005
212 CLOSTRIDIUM TEST POSITIVE 1 0.0005
213 ACCIDENT AT WORK 1 0.0005
214 FIBROMYALGIA 11 0.0005
215 FAECES PALE 1 0.0004
216 FACIAL PAIN 4 0.0004
217 PRODUCT PHYSICAL ISSUE 9 0.0004
218 APPLICATION SITE URTICARIA 1 0.0004
219 FEAR OF DEATH 1 0.0004
220 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
221 BRAIN OPERATION 1 0.0004
222 SENSORY DISTURBANCE 7 0.0004
223 SYNOVIAL CYST 2 0.0004
224 NECK PAIN 24 0.0004
225 SKIN TIGHTNESS 2 0.0004
226 VAGINAL INFECTION 2 0.0004
227 SPINAL COLUMN STENOSIS 2 0.0004
228 PULMONARY INFARCTION 1 0.0004
229 CHEST DISCOMFORT 43 0.0004
230 CHOLECYSTITIS 5 0.0004
231 APHAGIA 2 0.0004
232 GASTROINTESTINAL OBSTRUCTION 1 0.0004
233 PAINFUL RESPIRATION 1 0.0004
234 EYE OEDEMA 1 0.0004
235 APPLICATION SITE IRRITATION 5 0.0004
236 CATHETER SITE HAEMORRHAGE 1 0.0004
237 EYELID IRRITATION 1 0.0004
238 DRY THROAT 4 0.0004
239 APPENDICITIS PERFORATED 1 0.0004
240 MENOPAUSE 1 0.0004
241 TEMPERATURE INTOLERANCE 4 0.0004
242 DRUG TITRATION ERROR 1 0.0004
243 MALABSORPTION 2 0.0004
244 MULTIPLE ALLERGIES 3 0.0004
245 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
246 CHONDROPATHY 1 0.0004
247 ABDOMINAL RIGIDITY 1 0.0004
248 MIGRAINE WITH AURA 1 0.0004
249 CLUMSINESS 1 0.0004
250 BLOOD PHOSPHORUS INCREASED 1 0.0004
251 APPLICATION SITE HAEMORRHAGE 1 0.0004
252 CHOLELITHIASIS 12 0.0004
253 RHEUMATOID NODULE 1 0.0004
254 INTRACRANIAL PRESSURE INCREASED 2 0.0004
255 SERUM SICKNESS 1 0.0004
256 MACULAR OEDEMA 2 0.0004
257 BURNING SENSATION 25 0.0004
258 CHOLECYSTITIS ACUTE 2 0.0004
259 DRUG EFFECT DECREASED 19 0.0004
260 INJECTION SITE SCAR 1 0.0004
261 MUSCULOSKELETAL DISCOMFORT 6 0.0003
262 PSYCHOLOGICAL TRAUMA 3 0.0003
263 FIBULA FRACTURE 1 0.0003
264 HYPERVENTILATION 2 0.0003
265 BILIARY COLIC 1 0.0003
266 INJURY 24 0.0003
267 SINUS HEADACHE 2 0.0003
268 ATYPICAL PNEUMONIA 1 0.0003
269 OROPHARYNGEAL DISCOMFORT 3 0.0003
270 OSTEOPENIA 5 0.0003
271 JOINT INJURY 7 0.0003
272 IMPAIRED WORK ABILITY 7 0.0003
273 MASTICATION DISORDER 1 0.0003
274 ECTOPIC PREGNANCY 1 0.0003
275 INVESTIGATION 1 0.0003
276 DRUG EFFECT INCREASED 1 0.0003
277 THERAPEUTIC RESPONSE UNEXPECTED 14 0.0003
278 LOOSE TOOTH 1 0.0003
279 APPLICATION SITE VESICLES 2 0.0003
280 INCORRECT DISPOSAL OF PRODUCT 1 0.0003
281 BACK DISORDER 5 0.0003
282 DYSGRAPHIA 2 0.0003
283 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11 0.0003
284 CHEST PAIN 56 0.0003
285 EXPOSURE DURING BREAST FEEDING 1 0.0003
286 EXPIRED DEVICE USED 1 0.0003
287 NEPHRITIS 1 0.0003
288 COLITIS ISCHAEMIC 2 0.0003
289 SUPRAVENTRICULAR EXTRASYSTOLES 1 0.0003
290 APPLICATION SITE DRYNESS 1 0.0003
291 HEPATIC CYST 1 0.0003
292 PALPITATIONS 34 0.0003
293 DROOLING 2 0.0003
294 TACHYPHRENIA 1 0.0003
295 HEAD DISCOMFORT 5 0.0003
296 FIBRIN D DIMER INCREASED 1 0.0003
297 PRODUCT CONTAMINATION 1 0.0003
298 AGEUSIA 7 0.0003
299 PARAESTHESIA 44 0.0003
300 FACIAL BONES FRACTURE 1 0.0003
301 VISUAL FIELD DEFECT 2 0.0003
302 BONE DISORDER 5 0.0003
303 PANIC ATTACK 10 0.0003
304 FOOD INTOLERANCE 1 0.0003
305 MUSCULOSKELETAL PAIN 14 0.0003
306 APPLICATION SITE ERYTHEMA 7 0.0003
307 IMPULSIVE BEHAVIOUR 1 0.0003
308 PEMPHIGOID 2 0.0003
309 ROAD TRAFFIC ACCIDENT 11 0.0003
310 TROPONIN INCREASED 2 0.0003
311 CHOLECYSTECTOMY 3 0.0003
312 GASTRIC DISORDER 9 0.0003
313 SLEEP APNOEA SYNDROME 5 0.0003
314 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
315 GASTRIC INFECTION 1 0.0003
316 DISSOCIATION 2 0.0003
317 FEAR 7 0.0003
318 OESOPHAGEAL DISORDER 1 0.0003
319 FEELING ABNORMAL 62 0.0003
320 EPIGASTRIC DISCOMFORT 1 0.0003
321 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
322 OESOPHAGEAL PAIN 1 0.0003
323 ANXIETY 72 0.0003
324 UPPER LIMB FRACTURE 5 0.0003
325 CEREBRAL ATROPHY 1 0.0003
326 HYPERPHAGIA 1 0.0003
327 AZOTAEMIA 1 0.0003
328 SKIN PAPILLOMA 1 0.0002
329 SENSORY LOSS 2 0.0002
330 ORGAN FAILURE 1 0.0002
331 THERAPEUTIC RESPONSE DECREASED 15 0.0002
332 PERIPHERAL VENOUS DISEASE 1 0.0002
333 INJECTION SITE URTICARIA 6 0.0002
334 ANAPHYLACTOID REACTION 1 0.0002
335 TENDON RUPTURE 3 0.0002
336 APPLICATION SITE EXFOLIATION 1 0.0002
337 SPINAL STENOSIS 1 0.0002
338 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
339 HYPOAESTHESIA 36 0.0002
340 SUICIDAL BEHAVIOUR 1 0.0002
341 SLEEP TERROR 1 0.0002
342 MUSCLE FATIGUE 1 0.0002
343 POOR PERIPHERAL CIRCULATION 1 0.0002
344 VITAMIN D DECREASED 2 0.0002
345 LEFT VENTRICULAR HYPERTROPHY 1 0.0002
346 ABNORMAL SENSATION IN EYE 1 0.0002
347 HEPATIC LESION 1 0.0002
348 HORDEOLUM 1 0.0002
349 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
350 MONOPLEGIA 1 0.0002
351 URINE OUTPUT DECREASED 2 0.0002
352 FEELING HOT 14 0.0002
353 MELANOCYTIC NAEVUS 1 0.0002
354 DYSPHEMIA 1 0.0002
355 ONYCHOMYCOSIS 1 0.0002
356 PHYSICAL DISABILITY 1 0.0002
357 CATHETERISATION CARDIAC 1 0.0002
358 RHINITIS ALLERGIC 1 0.0002
359 DRUG EFFECT DELAYED 1 0.0002
360 APPLICATION SITE RASH 3 0.0002
361 ISCHAEMIA 1 0.0002
362 EYE OPERATION 1 0.0002
363 NERVE COMPRESSION 2 0.0002
364 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
365 NEPHROGENIC ANAEMIA 1 0.0002
366 DEEP VEIN THROMBOSIS 14 0.0002
367 ROSACEA 1 0.0002
368 GASTRITIS EROSIVE 1 0.0002
369 SOMNOLENCE 43 0.0002
370 GASTRIC ULCER 4 0.0002
371 PULMONARY EMBOLISM 20 0.0002
372 ENDOMETRIOSIS 1 0.0002
373 FAECAL INCONTINENCE 1 0.0002
374 PARAESTHESIA ORAL 3 0.0002
375 MENTAL IMPAIRMENT 5 0.0002
376 HORMONE LEVEL ABNORMAL 1 0.0002
377 INJECTION SITE INFLAMMATION 1 0.0002
378 HEPATIC ENZYME ABNORMAL 1 0.0002
379 HEART RATE DECREASED 7 0.0002
380 CORONARY ARTERY STENOSIS 1 0.0002
381 DYSPHORIA 1 0.0002
382 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
383 INSURANCE ISSUE 3 0.0002
384 EUPHORIC MOOD 2 0.0002
385 EAR DISCOMFORT 2 0.0002
386 RIB FRACTURE 4 0.0002
387 ANKLE FRACTURE 3 0.0002
388 STOMACH DISCOMFORT 1 0.0002
389 DRUG EFFECT INCOMPLETE 7 0.0002
390 CRYING 7 0.0002
391 EYE DISCHARGE 2 0.0002
392 CONVULSION 11 0.0002
393 SWOLLEN TONGUE 6 0.0002
394 TENDERNESS 2 0.0002
395 APLASTIC ANAEMIA 1 0.0002
396 ANHEDONIA 5 0.0002
397 BLOOD LACTIC ACID INCREASED 1 0.0002
398 RENAL PAIN 2 0.0002
399 DYSARTHRIA 7 0.0002
400 STRESS FRACTURE 1 0.0002
401 BEHAVIOUR DISORDER 1 0.0002
402 PHARYNGITIS STREPTOCOCCAL 2 0.0002
403 NAUSEA 146 0.0002
404 LIMB INJURY 5 0.0002
405 DYSPEPSIA 18 0.0002
406 APPLICATION SITE PAIN 4 0.0002
407 CHOKING SENSATION 1 0.0002
408 HYPERKERATOSIS 1 0.0002
409 ABNORMAL DREAMS 5 0.0002
410 INJECTION SITE INJURY 1 0.0002
411 LIP SWELLING 6 0.0002
412 STEVENS-JOHNSON SYNDROME 4 0.0002
413 HEART RATE ABNORMAL 1 0.0002
414 DIZZINESS 89 0.0002
415 EYE INFECTION 2 0.0002
416 HEMIPARESIS 3 0.0002
417 FLUSHING 18 0.0002
418 COLECTOMY 1 0.0002
419 PERIORBITAL SWELLING 1 0.0002
420 APPLICATION SITE PRURITUS 4 0.0002
421 PERONEAL NERVE PALSY 1 0.0002
422 IMPAIRED DRIVING ABILITY 2 0.0002
423 SINUSITIS 18 0.0002
424 HEADACHE 110 0.0002
425 DERMATITIS CONTACT 2 0.0002
426 NEUROLOGICAL SYMPTOM 1 0.0002
427 ABDOMINAL PAIN UPPER 36 0.0002
428 PARANOIA 3 0.0002
429 CORONARY ARTERY BYPASS 1 0.0002
430 GASTRIC HAEMORRHAGE 2 0.0002
431 SKIN ATROPHY 1 0.0002
432 MUSCLE TWITCHING 4 0.0002
433 BLOOD URIC ACID INCREASED 1 0.0002
434 SKIN WARM 1 0.0002
435 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
436 COLD SWEAT 3 0.0002
437 LYMPHOCYTE COUNT DECREASED 3 0.0002
438 DECREASED INTEREST 1 0.0002
439 ENERGY INCREASED 1 0.0002
440 PRODUCT QUALITY ISSUE 23 0.0002
441 ODYNOPHAGIA 1 0.0002
442 ACCIDENT 2 0.0002
443 MULTIPLE SCLEROSIS 8 0.0002
444 PROTHROMBIN TIME PROLONGED 1 0.0002
445 APHASIA 5 0.0002
446 END STAGE RENAL DISEASE 3 0.0002
447 VOMITING 77 0.0002
448 LARYNGEAL OEDEMA 1 0.0002
449 ABASIA 4 0.0002
450 SCOLIOSIS 1 0.0002
451 OLIGURIA 1 0.0002
452 ABDOMINAL DISCOMFORT 27 0.0002
453 NASAL DRYNESS 1 0.0002
454 INFUSION SITE SWELLING 1 0.0002
455 BLEPHAROSPASM 1 0.0002
456 UNEVALUABLE EVENT 12 0.0002
457 BRAIN OEDEMA 2 0.0002
458 PHOTOPSIA 1 0.0002
459 HAEMATEMESIS 4 0.0002
460 FEELING JITTERY 3 0.0002
461 FOREIGN BODY SENSATION IN EYES 1 0.0002
462 ENTERITIS 1 0.0002
463 ROTATOR CUFF SYNDROME 2 0.0002
464 GALACTORRHOEA 1 0.0002
465 INCOHERENT 1 0.0002
466 CHOKING 3 0.0002
467 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
468 NODULE 2 0.0002
469 BRADYPHRENIA 1 0.0002
470 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
471 HYPOGAMMAGLOBULINAEMIA 1 0.0002
472 BEDRIDDEN 2 0.0002
473 GASTRITIS 4 0.0002
474 ADVERSE EVENT 14 0.0002
475 IMMUNE SYSTEM DISORDER 2 0.0002
476 DISABILITY 3 0.0002
477 SINUS DISORDER 3 0.0002
478 EAR INFECTION 4 0.0002
479 SKIN MASS 1 0.0001
480 MUSCULAR WEAKNESS 17 0.0001
481 MALIGNANT MELANOMA 2 0.0001
482 POST-TRAUMATIC STRESS DISORDER 1 0.0001
483 SINUS CONGESTION 2 0.0001
484 UVEITIS 2 0.0001
485 PRODUCT LABEL ISSUE 1 0.0001
486 IMPAIRED GASTRIC EMPTYING 2 0.0001
487 ABNORMAL LOSS OF WEIGHT 1 0.0001
488 GINGIVAL BLEEDING 2 0.0001
489 CORONARY ARTERY OCCLUSION 2 0.0001
490 ADVERSE DRUG REACTION 13 0.0001
491 HAIR GROWTH ABNORMAL 1 0.0001
492 FEELING COLD 4 0.0001
493 DRUG INEFFECTIVE 189 0.0001
494 APPLICATION SITE REACTION 1 0.0001
495 SEASONAL ALLERGY 2 0.0001
496 EATING DISORDER 3 0.0001
497 DIVERTICULUM 1 0.0001
498 PARALYSIS 2 0.0001
499 ANGINA PECTORIS 4 0.0001
500 HYPERSOMNIA 4 0.0001
501 POOR QUALITY SLEEP 3 0.0001
502 PANIC REACTION 1 0.0001
503 SWELLING FACE 9 0.0001
504 MENTAL DISORDER 6 0.0001
505 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
506 MAJOR DEPRESSION 1 0.0001
507 AGITATION 10 0.0001
508 BLINDNESS TRANSIENT 1 0.0001
509 PSYCHIATRIC SYMPTOM 1 0.0001
510 HYPOPHOSPHATAEMIA 1 0.0001
511 CEREBRAL DISORDER 1 0.0001
512 TOOTH DISORDER 3 0.0001
513 HYPERSENSITIVITY 25 0.0001
514 EYE SWELLING 5 0.0001
515 SUNBURN 1 0.0001
516 THROAT IRRITATION 6 0.0001
517 KETOACIDOSIS 1 0.0001
518 BREAST TENDERNESS 1 0.0001
519 HOT FLUSH 10 0.0001
520 ECONOMIC PROBLEM 2 0.0001
521 HYPERHIDROSIS 17 0.0001
522 ILL-DEFINED DISORDER 8 0.0001
523 AORTIC ANEURYSM 1 0.0001
524 LIPASE INCREASED 1 0.0001
525 RENAL FAILURE CHRONIC 1 0.0001
526 OROPHARYNGEAL PAIN 12 0.0001
527 ATRIOVENTRICULAR BLOCK 1 0.0001
528 LIMB DISCOMFORT 4 0.0001
529 HAEMORRHAGIC STROKE 1 0.0001
530 DEPRESSION 29 0.0001
531 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
532 BLOOD ALBUMIN DECREASED 1 0.0001
533 ULCER 2 0.0001
534 MUSCULOSKELETAL STIFFNESS 11 0.0001
535 MOOD SWINGS 4 0.0001
536 INJECTION SITE BRUISING 10 0.0001
537 BLOOD PRESSURE FLUCTUATION 3 0.0001
538 MOVEMENT DISORDER 4 0.0001
539 EYE PAIN 7 0.0001
540 LOCALISED INFECTION 3 0.0001
541 RHINITIS 1 0.0001
542 MUSCLE DISORDER 1 0.0001
543 DRY MOUTH 10 0.0001
544 DYSKINESIA 5 0.0001
545 POST PROCEDURAL INFECTION 1 0.0001
546 BLINDNESS 5 0.0001
547 ESCHERICHIA INFECTION 1 0.0001
548 HAIR DISORDER 1 0.0001
549 HEART RATE INCREASED 12 0.0001
550 TREMOR 20 0.0001
551 PAIN 74 0.0001
552 VISUAL ACUITY REDUCED 4 0.0001
553 COAGULOPATHY 2 0.0001
554 COMPLETED SUICIDE 10 0.0001
555 LIVE BIRTH 1 0.0001
556 SENSATION OF FOREIGN BODY 1 0.0001
557 CHRONIC KIDNEY DISEASE 9 0.0001
558 CANDIDA INFECTION 2 0.0001
559 MYALGIA 20 0.0001
560 LOSS OF CONSCIOUSNESS 15 0.0001
561 INSOMNIA 31 0.0001
562 SKIN HYPERPIGMENTATION 1 0.0001
563 ANAPHYLACTIC SHOCK 3 0.0001
564 EMOTIONAL DISTRESS 14 0.0001
565 CARDIAC MURMUR 1 0.0001
566 DIPLOPIA 3 0.0001
567 SKIN SWELLING 1 0.0001
568 RESPIRATORY TRACT INFECTION 3 0.0001
569 VERTIGO 7 0.0001
570 DEAFNESS 3 0.0001
571 SEDATION 3 0.0001
572 SPEECH DISORDER 6 0.0001
573 BLOOD CALCIUM INCREASED 1 0.0001
574 MALAISE 50 0.0001
575 DEVICE MALFUNCTION 8 0.0001
576 URTICARIA 19 0.0001
577 SLEEP DISORDER 8 0.0001
578 LUNG INFILTRATION 1 0.0001
579 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
580 RESPIRATORY RATE INCREASED 1 0.0001
581 SKIN BURNING SENSATION 8 0.0001
582 GASTROINTESTINAL DISORDER 10 0.0001
583 GOUT 2 0.0001
584 DISTURBANCE IN ATTENTION 6 0.0001
585 BLOOD PRESSURE INCREASED 17 0.0001
586 OPTIC NEURITIS 1 0.0001
587 INFLUENZA LIKE ILLNESS 9 0.0001
588 SUICIDAL IDEATION 10 0.0001
589 NEPHROLITHIASIS 5 0.0001
590 BRAIN NEOPLASM 1 0.0001
591 SKIN DISCOLOURATION 5 0.0001
592 MEDICATION ERROR 6 0.0001
593 PRODUCT DISTRIBUTION ISSUE 1 0.0001
594 PERSONALITY CHANGE 1 0.0001
595 BLOOD CHOLESTEROL INCREASED 5 0.0001
596 MIDDLE INSOMNIA 2 0.0001
597 DIARRHOEA HAEMORRHAGIC 1 0.0001
598 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
599 PHOTOPHOBIA 2 0.0001
600 LACERATION 1 0.0001
601 SQUAMOUS CELL CARCINOMA 1 0.0001
602 SPUTUM DISCOLOURED 1 0.0001
603 RED BLOOD CELL COUNT DECREASED 3 0.0001
604 EYE INFLAMMATION 1 0.0001
605 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
606 LETHARGY 6 0.0001
607 LOWER LIMB FRACTURE 2 0.0001
608 AFFECT LABILITY 1 0.0001
609 ATELECTASIS 1 0.0001
610 PRESCRIBED OVERDOSE 2 0.0001
611 AUTOIMMUNE DISORDER 1 0.0001
612 BONE PAIN 6 0.0001
613 SURGERY 6 0.0001
614 KIDNEY INFECTION 2 0.0001
615 ACUTE MYOCARDIAL INFARCTION 3 0.0001
616 HOSPICE CARE 1 0.0001
617 LIGAMENT SPRAIN 1 0.0001
618 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
619 DISORIENTATION 4 0.0001
620 HAEMATOCRIT DECREASED 2 0.0001
621 INABILITY TO AFFORD MEDICATION 1 0.0001
622 OVARIAN CYST 1 0.0001
623 SALIVARY HYPERSECRETION 1 0.0001
624 LACRIMATION INCREASED 3 0.0001
625 EXTRA DOSE ADMINISTERED 4 0.0001
626 FEEDING DISORDER 2 0.0001
627 OEDEMA PERIPHERAL 12 0.0001
628 EYELID PTOSIS 1 0.0001
629 SUBARACHNOID HAEMORRHAGE 1 0.0001
630 MOTOR DYSFUNCTION 1 0.0001
631 INJECTION SITE RASH 3 0.0001
632 NEUTROPHIL COUNT INCREASED 1 0.0001
633 INITIAL INSOMNIA 1 0.0001
634 MYOCARDIAL INFARCTION 17 0.0001
635 DRUG DOSE OMISSION 16 0.0001
636 PAIN IN EXTREMITY 28 0.0001
637 DRUG ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
638 DYSPHAGIA 9 0.0001
639 SCRATCH 1 0.0001
640 HALLUCINATION, VISUAL 2 0.0001
641 MEMORY IMPAIRMENT 13 0.0001
642 JOINT DISLOCATION 1 0.0001
643 OSTEOARTHRITIS 4 0.0001
644 RASH 41 0.0001
645 RETCHING 2 0.0001
646 BREAST PAIN 1 0.0001
647 HEREDITARY ANGIOEDEMA 1 0.0001
648 PRURITUS GENERALISED 2 0.0001
649 FAECES DISCOLOURED 2 0.0001
650 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
651 INJECTION SITE SWELLING 7 0.0001
652 INJECTION SITE NODULE 1 0.0001
653 DENTAL CARIES 1 0.0001
654 RENAL FAILURE 12 0.0001
655 DYSPNOEA 51 0.0001
656 FUNGAL INFECTION 3 0.0001
657 SYNCOPE 9 0.0001
658 INFLUENZA 10 0.0001
659 INJECTION SITE PRURITUS 6 0.0001
660 MALNUTRITION 1 0.0001
661 ORAL PAIN 2 0.0001
662 SKIN INFECTION 1 0.0001
663 FISTULA 1 0.0001
664 BLOOD CALCIUM DECREASED 1 0.0001
665 GAIT DISTURBANCE 17 0.0001
666 HEART RATE IRREGULAR 2 0.0001
667 MITRAL VALVE INCOMPETENCE 1 0.0001
668 DRUG INTERACTION 14 0.0001
669 SCAB 1 0.0001
670 MICTURITION URGENCY 1 0.0001
671 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
672 VISION BLURRED 12 0.0001
673 FATIGUE 68 0.0001
674 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
675 PERICARDIAL EFFUSION 2 0.0001
676 MADAROSIS 1 0.0001
677 EYELID OEDEMA 1 0.0001
678 SPINAL PAIN 1 0.0001
679 BLOOD IRON DECREASED 1 0.0001
680 ATAXIA 1 0.0001
681 PRODUCT ADHESION ISSUE 3 0.0001
682 RASH ERYTHEMATOUS 4 0.0001
683 POLYNEUROPATHY 1 0.0001
684 NOCTURIA 1 0.0001
685 PRESYNCOPE 2 0.0001
686 RESTLESSNESS 3 0.0001
687 CEREBRAL INFARCTION 2 0.0001
688 SMALL INTESTINAL OBSTRUCTION 1 0.0001
689 BRONCHITIS 6 0.0001
690 INJECTION SITE EXTRAVASATION 1 0.0001
691 PHARYNGITIS 1 0.0001
692 INJECTION SITE ERYTHEMA 10 0.0001
693 DRY EYE 4 0.0001
694 ABDOMINAL PAIN LOWER 2 0.0001
695 MUSCLE ATROPHY 1 0.0001
696 OVERDOSE 17 0.0001
697 TACHYCARDIA 7 0.0001
698 FLUID RETENTION 4 0.0001
699 DEVICE DEPLOYMENT ISSUE 1 0.0001
700 CONSTIPATION 17 0.0001
701 MYDRIASIS 1 0.0001
702 THERAPY CESSATION 4 0.0001
703 INFUSION SITE PAIN 1 0.0001
704 RHINORRHOEA 5 0.0001
705 HIATUS HERNIA 1 0.0001
706 INJECTION SITE INDURATION 1 0.0001
707 PLATELET COUNT INCREASED 1 0.0001
708 ABDOMINAL DISTENSION 8 0.0001
709 ALOPECIA 15 0.0001
710 WEIGHT INCREASED 17 0.0001
711 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
712 DEPRESSED MOOD 4 0.0001
713 HYPERTENSION 16 0.0001
714 DYSMENORRHOEA 1 0.0001
715 ADVERSE REACTION 1 0.0001
716 INJECTION SITE HAEMORRHAGE 6 0.0001
717 EYE HAEMORRHAGE 1 0.0001
718 CARDIAC DISORDER 7 0.0001
719 HAIR TEXTURE ABNORMAL 1 0.0001
720 MENSTRUATION IRREGULAR 2 0.0001
721 JOINT RANGE OF MOTION DECREASED 1 0.0001
722 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
723 RASH PRURITIC 4 0.0001
724 OEDEMA 4 0.0001
725 TACHYPNOEA 1 0.0001
726 PALLOR 2 0.0001
727 AKATHISIA 1 0.0001
728 TREATMENT NONCOMPLIANCE 4 0.0001
729 OSTEOPOROSIS 3 0.0001
730 PERIPHERAL COLDNESS 1 0.0001
731 FALL 24 0.0001
732 ARTHROPATHY 4 0.0001
733 ASTHENIA 27 0.0001
734 CARPAL TUNNEL SYNDROME 1 0.0001
735 TOXICITY TO VARIOUS AGENTS 12 0.0001
736 NASOPHARYNGITIS 13 0.0001
737 SINUS TACHYCARDIA 1 0.0001
738 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 5 0.0001
739 SEIZURE 8 0.0001
740 MYELODYSPLASTIC SYNDROME 1 0.0001
741 VAGINAL HAEMORRHAGE 3 0.0001
742 CONDITION AGGRAVATED 21 0.0001
743 INJECTION SITE HAEMATOMA 1 0.0001
744 HYPOKINESIA 1 0.0001
745 BACK PAIN 16 0.0001
746 ABDOMINAL PAIN 16 0.0001
747 FLUID OVERLOAD 1 0.0001
748 DYSSTASIA 2 0.0001
749 CHILLS 8 0.0001
750 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
751 DRUG WITHDRAWAL SYNDROME NEONATAL 1 0.0001
752 RENAL INJURY 2 0.0001
753 PULMONARY MASS 1 0.0001
754 IMMUNODEFICIENCY 1 0.0001
755 BONE LOSS 1 0.0001
756 IRRITABILITY 4 0.0001
757 HYPOAESTHESIA ORAL 1 0.0001
758 DEVICE FAILURE 1 0.0001
759 DISCOMFORT 4 0.0001
760 DRUG DISPENSING ERROR 1 0.0001
761 EPILEPSY 2 0.0001
762 TINNITUS 3 0.0001
763 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
764 VISUAL IMPAIRMENT 8 0.0001
765 EXPOSURE DURING PREGNANCY 4 0.0001
766 EJECTION FRACTION DECREASED 1 0.0001
767 COGNITIVE DISORDER 3 0.0001
768 NERVOUS SYSTEM DISORDER 2 0.0001
769 BRAIN FOG 1 0.0001
770 CYANOSIS 1 0.0001
771 ARTHRITIS 5 0.0001
772 ARRHYTHMIA 3 0.0001
773 HEAD INJURY 2 0.0001
774 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
775 RESPIRATORY TRACT CONGESTION 1 0.0001
776 METABOLIC ACIDOSIS 2 0.0001
777 ARTHRALGIA 26 0.0001
778 NIGHT SWEATS 2 0.0001
779 INJECTION SITE PAIN 19 0.0001
780 CONFUSIONAL STATE 10 0.0001
781 RHEUMATOID ARTHRITIS 7 0.0001
782 BLOOD POTASSIUM INCREASED 1 0.0001
783 PRODUCT DOSE OMISSION 4 0.0001
784 PHOTOSENSITIVITY REACTION 1 0.0001
785 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
786 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
787 BLOOD PRESSURE DECREASED 4 0.0001
788 SKIN DISORDER 2 0.0001
789 BLOOD UREA INCREASED 1 0.0001
790 EYE PRURITUS 2 0.0001
791 FACE OEDEMA 1 0.0001
792 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
793 ANGER 2 0.0001
794 CEREBROVASCULAR ACCIDENT 10 0.0001
795 HEPATIC ENZYME INCREASED 4 0.0001
796 METRORRHAGIA 1 0.0001
797 INJECTION SITE REACTION 4 0.0001
798 JOINT SWELLING 7 0.0001
799 ORTHOSTATIC HYPOTENSION 1 0.0001
800 NERVOUSNESS 3 0.0001
801 LOCAL SWELLING 1 0.0001
802 DIARRHOEA 37 0.0001
803 AMENORRHOEA 1 0.0001
804 HYPERKALAEMIA 2 0.0001
805 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
806 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
807 CEREBRAL HAEMORRHAGE 2 0.0001
808 LEUKOCYTOSIS 1 0.0001
809 UNDERDOSE 4 0.0001
810 ACCIDENTAL OVERDOSE 2 0.0001
811 MUSCLE SPASMS 10 0.0001
812 HAEMATOCHEZIA 3 0.0001
813 ANAPHYLACTIC REACTION 3 0.0001
814 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
815 INJECTION SITE MASS 2 0.0001
816 DYSGEUSIA 4 0.0001
817 HEPATIC STEATOSIS 1 0.0001
818 BLISTER 3 0.0001
819 OXYGEN SATURATION DECREASED 3 0.0001
820 HALLUCINATION 4 0.0001
821 BLOOD SODIUM DECREASED 1 0.0001
822 FLATULENCE 3 0.0001
823 BLOOD URINE PRESENT 1 0.0001
824 MUSCULOSKELETAL DISORDER 1 0.0001
825 DEHYDRATION 7 0.0001
826 ANAEMIA 10 0.0001
827 PULMONARY FIBROSIS 1 0.0001
828 PRODUCT SUBSTITUTION ISSUE 3 0.0001
829 POST PROCEDURAL COMPLICATION 1 0.0001
830 DRUG PRESCRIBING ERROR 1 0.0001
831 ACUTE RESPIRATORY FAILURE 1 0.0001
832 GLAUCOMA 1 0.0001
833 GENERAL PHYSICAL HEALTH DETERIORATION 6 0.0001
834 ERUCTATION 1 0.0001
835 DYSTONIA 1 0.0001
836 DYSPHONIA 3 0.0001
837 HAEMORRHOIDS 1 0.0001
838 ORAL HERPES 1 0.0001
839 NASAL CONGESTION 3 0.0001
840 SPINAL FRACTURE 1 0.0000
841 PNEUMONIA 16 0.0000
842 PLEURAL EFFUSION 3 0.0000
843 TASTE DISORDER 1 0.0000
844 PRODUCT PREPARATION ERROR 1 0.0000
845 ERYTHEMA 10 0.0000
846 PULMONARY HYPERTENSION 1 0.0000
847 POLLAKIURIA 2 0.0000
848 DERMATITIS 1 0.0000
849 KNEE ARTHROPLASTY 1 0.0000
850 PRURITUS 18 0.0000
851 LIVER FUNCTION TEST INCREASED 1 0.0000
852 RECTAL HAEMORRHAGE 2 0.0000
853 HYPOACUSIS 2 0.0000
854 DEVICE LEAKAGE 2 0.0000
855 AMNESIA 3 0.0000
856 PRODUCT DISPENSING ERROR 1 0.0000
857 ACUTE KIDNEY INJURY 7 0.0000
858 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
859 COVID-19 8 0.0000
860 PERIPHERAL SWELLING 7 0.0000
861 MELAENA 1 0.0000
862 ANGIOEDEMA 2 0.0000
863 RASH MACULO-PAPULAR 1 0.0000
864 GLOSSODYNIA 1 0.0000
865 RASH PAPULAR 1 0.0000
866 THERAPY NON-RESPONDER 2 0.0000
867 PANCREATITIS ACUTE 1 0.0000
868 PRODUCT AVAILABILITY ISSUE 1 0.0000
869 INCORRECT DOSE ADMINISTERED 10 0.0000
870 PYREXIA 15 0.0000
871 COUGH 12 0.0000
872 SWELLING 4 0.0000
873 OCULAR HYPERAEMIA 2 0.0000
874 PRODUCT PRESCRIBING ERROR 1 0.0000
875 PRODUCTIVE COUGH 2 0.0000
876 CONTUSION 4 0.0000
877 DRUG INTOLERANCE 4 0.0000
878 LIVER INJURY 1 0.0000
879 ENCEPHALOPATHY 1 0.0000
880 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
881 EPISTAXIS 3 0.0000
882 LEUKOPENIA 2 0.0000
883 AGGRESSION 2 0.0000
884 ACNE 3 0.0000
885 WEIGHT DECREASED 11 0.0000
886 CARDIOVASCULAR DISORDER 1 0.0000
887 DIABETES MELLITUS 3 0.0000
888 HYPOPHAGIA 1 0.0000
889 HEPATITIS 1 0.0000
890 RASH GENERALISED 1 0.0000
891 EXPOSURE VIA SKIN CONTACT 1 0.0000
892 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
893 ECZEMA 2 0.0000
894 JOINT STIFFNESS 1 0.0000
895 PANCREATITIS 2 0.0000
896 BREAST CANCER FEMALE 1 0.0000
897 CARDIAC FAILURE CONGESTIVE 3 0.0000
898 PAIN OF SKIN 1 0.0000
899 BLOOD BILIRUBIN INCREASED 1 0.0000
900 SKIN LESION 1 0.0000
901 RESPIRATORY ARREST 1 0.0000
902 TREATMENT FAILURE 3 0.0000
903 PROCEDURAL PAIN 1 0.0000
904 MENTAL STATUS CHANGES 1 0.0000
905 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
906 RENAL IMPAIRMENT 3 0.0000
907 TARDIVE DYSKINESIA 1 0.0000
908 ASTHMA 4 0.0000
909 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
910 URINARY TRACT INFECTION 6 0.0000
911 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
912 EYE IRRITATION 2 0.0000
913 BALANCE DISORDER 3 0.0000
914 LIVER FUNCTION TEST ABNORMAL 1 0.0000
915 DRUG WITHDRAWAL SYNDROME 3 0.0000
916 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
917 PSYCHOTIC DISORDER 1 0.0000
918 WHEEZING 2 0.0000
919 CATARACT 2 0.0000
920 EMOTIONAL DISORDER 1 0.0000
921 CYSTITIS 1 0.0000
922 HYPOTHYROIDISM 1 0.0000
923 DEVICE EXPULSION 2 0.0000
924 BLOOD CREATININE INCREASED 2 0.0000
925 PSORIASIS 4 0.0000
926 IMPAIRED HEALING 1 0.0000
927 EYE DISORDER 1 0.0000
928 DECREASED APPETITE 7 0.0000
929 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
930 DRUG EXPOSURE DURING PREGNANCY 1 0.0000
931 DELIRIUM 1 0.0000
932 HAEMORRHAGE 3 0.0000
933 RASH MACULAR 1 0.0000
934 HYPOXIA 1 0.0000
935 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
936 DYSURIA 1 0.0000
937 THROMBOCYTOPENIA 3 0.0000
938 ABNORMAL BEHAVIOUR 1 0.0000
939 HYPOTENSION 5 0.0000
940 THROMBOSIS 2 0.0000
941 PSORIATIC ARTHROPATHY 1 0.0000
942 NEUTROPHIL COUNT DECREASED 1 0.0000
943 LUNG NEOPLASM MALIGNANT 1 0.0000
944 CARDIAC ARREST 2 0.0000
945 CARDIO-RESPIRATORY ARREST 1 0.0000
946 PRODUCT DOSE OMISSION ISSUE 7 0.0000
947 SKIN EXFOLIATION 2 0.0000
948 RENAL FAILURE ACUTE 1 0.0000
949 LIVER DISORDER 1 0.0000
950 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
951 OFF LABEL USE 19 0.0000
952 HYPOKALAEMIA 1 0.0000
953 RENAL DISORDER 1 0.0000
954 NEUROPATHY PERIPHERAL 2 0.0000
955 DISEASE RECURRENCE 1 0.0000
956 BLOOD GLUCOSE DECREASED 1 0.0000
957 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
958 LUNG DISORDER 1 0.0000
959 HOSPITALISATION 3 0.0000
960 HAEMOGLOBIN DECREASED 2 0.0000
961 ILLNESS 2 0.0000
962 BRADYCARDIA 1 0.0000
963 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
964 PLATELET COUNT DECREASED 2 0.0000
965 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
966 SEPSIS 2 0.0000
967 PANCYTOPENIA 1 0.0000
968 HERPES ZOSTER 1 0.0000
969 NO ADVERSE EVENT 3 0.0000
970 SUICIDE ATTEMPT 1 0.0000
971 STOMATITIS 1 0.0000
972 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
973 DEVICE DIFFICULT TO USE 1 0.0000
974 MOBILITY DECREASED 1 0.0000
975 INFECTION 2 0.0000
976 DRUG DOSE OMISSION BY DEVICE 1 0.0000
977 PROSTATE CANCER 1 0.0000
978 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
979 PRODUCT USE IN UNAPPROVED INDICATION 3 0.0000
980 DRUG ABUSE 1 0.0000
981 PRODUCT STORAGE ERROR 1 0.0000
982 INTENTIONAL PRODUCT MISUSE 1 0.0000
983 DEVICE ISSUE 1 0.0000
984 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
985 BREAST CANCER 1 0.0000
986 BLOOD GLUCOSE INCREASED 2 0.0000
987 DISEASE PROGRESSION 1 0.0000
988 DEATH 6 0.0000
989 DRUG DEPENDENCE 1 0.0000
990 PRODUCT USE ISSUE 1 0.0000